Document Detail


The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients.
MedLine Citation:
PMID:  8846536     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To investigate EPO-induced increase of hemoglobin on energy metabolism plasma concentrations of lactate (L), pyruvate (P) and excess lactate (XL) were determined in ten dialysis patients at rest, immediately after 6 minutes of ergometric exercise as well as after recovery for 15 and 30 min. The investigations were performed before EPO-therapy at a mean Hb = 7.5 +/- 0.9 g/dl and under EPO-therapy at a mean Hb = 10.0 +/- 0.6 g/dl and at a mean Hb = 11.9 +/- 0.8 g/dl. Ten healthy subjects were subjected to the same investigation at Hb = 14.7 +/- 1.1 g/dl. There was a significant rise of L and XL in all patient groups under ergometric exercise. The increase of hemoglobin from 7.5 g/dl to 10.0 g/dl led to significantly (p < 0.01) lower L and XL concentrations immediately after exercise (L = 4.62 vs 3.23 mmol/l, XL = 2.37 vs 1.38 mmol/l). The further decrease of the mean L and XL values (L = 2.88 mmol/l, XL = 1.05 mmol/l) associated with the rise of hemoglobin to 11.9 g/dl could not be confirmed statistically. In contrast to all patient groups, there was no significant rise in XL in the healthy control subjects under physical exercise. The present results make it evident that patients with renal anemia react even to light physical exercise with pronounced tissue hypoxia in contrast to healthy subjects. The increase of the hemoglobin content under the EPO-therapy leads to a marked reduction of the tissue hypoxia and consequently of anaerobic energy production. A further rise of the hemoglobin content above and beyond 10.5 g/dl will have an additional positive effect on oxygen supply only in occasional cases. The comparison with healthy subjects shows that despite a very large degree of normalization of the hemoglobin content, no normalization of energy metabolism can be attained.
Authors:
R Meierhenrich; H Jedicke; A Voigt; H Lange
Related Documents :
2125176 - Lactate and potassium fluxes from human skeletal muscle during and after intense, dynam...
8195526 - Critical capillary oxygen partial pressure and lactate threshold in patients with cardi...
22981226 - Subaortic right ventricular characteristics and relationship to exercise capacity in co...
15049576 - Pyruvate dehydrogenase deficiency in a sussex spaniel.
10548966 - Metabolic functions of l-carnitine and its effects as feed additive in horses. a review.
8315366 - Effects of income on drug choice in humans.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical nephrology     Volume:  45     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  1996 Feb 
Date Detail:
Created Date:  1996-10-24     Completed Date:  1996-10-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  90-7     Citation Subset:  IM; S    
Affiliation:
Department of Nephrology, Philipps-University of Marburg/Lahn, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anaerobic Threshold
Anemia / drug therapy*,  etiology,  metabolism
Case-Control Studies
Energy Metabolism
Erythropoietin / therapeutic use*
Exercise / physiology*
Exercise Test
Female
Humans
Kidney Failure, Chronic / complications,  metabolism*,  therapy
Lactates / blood*
Lactic Acid
Male
Middle Aged
Pyruvates / blood*
Pyruvic Acid
Recombinant Proteins / therapeutic use
Renal Dialysis*
Chemical
Reg. No./Substance:
0/Lactates; 0/Pyruvates; 0/Recombinant Proteins; 11096-26-7/Erythropoietin; 127-17-3/Pyruvic Acid; 50-21-5/Lactic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control stu...
Next Document:  Evidence that treatment of ESRD patients with recombinant human erythropoietin induces immunosuppres...